On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.
John MendelsohnProfessor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy - The University of Texas MD Anderson Cancer Center